Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeremy P. Harris, MD"'
Autor:
Rufus Banks, BS, Jino Park, MD, Linda Doan, MD, PhD, Erin Healy, MD, Jeremy P. Harris, MD, MPhil
Publikováno v:
JAAD Case Reports, Vol 47, Iss , Pp 50-53 (2024)
Externí odkaz:
https://doaj.org/article/53e8ca6f678547baacb09b6e025011b1
Autor:
David J. Benjamin, MD, Shuai Chen, PhD, Joanna B. Eldredge, MD, Shiruyeh Schokrpur, MD, Debory Li, Zhikuan Quan, MS, Jason W. Chan, MD, Amy L. Cummings, MD, Megan E. Daly, MD, Jonathan W. Goldman, MD, Matthew A. Gubens, MD, Jeremy P. Harris, MD, Mark W. Onaitis, MD, Viola W. Zhu, MD, PhD, Sandip P. Patel, MD, Karen Kelly, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100427- (2022)
Introduction: There is a paucity of data on immune checkpoint inhibitors (ICIs) plus doublet chemotherapy (C) in patients with advanced lung cancer whose tumor harbors an actionable mutation. We sought to provide insight into the role of this combina
Externí odkaz:
https://doaj.org/article/3801fd9322224ff8af798db8607d43fe
Autor:
Jeremy P. Harris MD, MPhil, Jino Park MD, Eric Ku MD, Steven Seyedin MD, Russell Stitzlein MD, Amanda Goldin MD, Wen-Pin Chen MS, Christine McLaren PhD, Allen M. Chen MD, Warren Chow MD
Publikováno v:
Cancer Control, Vol 31 (2024)
Objectives Immunotherapy with immune checkpoint inhibitors has shown only limited success in the management of metastatic soft tissue sarcoma. Overall response rates (ORR) with single agent pembrolizumab were 18% and median PFS was 18 weeks on the cl
Externí odkaz:
https://doaj.org/article/23421601d64348b5b1e00f854fbf53db